Important note: Information in this article was accurate in 2009. The state of the art may have changed since the publication date.
|
|
United Press International - April 30, 2009
Researchers led by University of Berne Professor Matthias Egger said they found mortality rates of people starting HIV treatment in four African countries approach those of the general population over time -- provided treatment is started before the immune system has been severely damaged.
In sub-Saharan Africa more than 2 million people with HIV now receive anti-retroviral treatment and mortality in HIV-infected patients who have access to that treatment is declining.
In the new study, Egger and colleagues investigated how mortality among HIV-infected people starting anti-retroviral treatment compares with non-HIV related mortality in Cote d'Ivoire, Malawi, South Africa, and Zimbabwe.
The researchers said their findings indicate mortality among HIV-infected people during the first two years of treatment is higher than in the general population in the four sub-Saharan countries. However, for patients who start anti-retroviral treatment when they have no signs of advanced HIV disease, the excess mortality is moderate and similar to that associated with diabetes.
The research appears in the journal PLoS Medicine.
090430
UP090417
Copyright © 2009 - United Press International. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through United Press International, Permissions Desk, 1510 H St. N.W. Washington DC 2005. Main Phone Switchboard: 202-898-8000 FAX: 202-898-8057 or 202-898-8147 Email: info@upi.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Elton John AIDS Foundation UK, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.
Always watch for outdated information. This article first appeared in 2009. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2009. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .